Details

Autor(en) / Beteiligte

• Gaudillière, Jean-Paul[Herausgeber]
• Hess, Volker[Herausgeber]

Titel

Ways of Regulating Drugs in the 19th and 20th Centuries [electronic resource]

Ort / Verlag

London : Palgrave Macmillan UK

Erscheinungsjahr

2013

Link zum Volltext

• SpringerLink Books - AutoHoldings

Beschreibungen/Notizen

• Description based upon print version of record.
• Includes bibliographical references at the end of each chapters and index.
• Cover; Title; Copyright; Dedication; Contents; List of Tables; List of Figures; Notes on Contributors; General Introduction ; 1 Secrets, Bureaucracy, and the Public: Drug Regulation in Early 19th-Century Prussia
• 2 Making Salvarsan: Experimental Therapy and the Development and Marketing of Salvarsan at the Crossroads of Science, Clinical Medicine, Industry, and Public Health 3 Professional and Industrial Drug Regulation in France and Germany: The Trajectories of Plant Extracts
• 4 Making Risks Visible: The Science, Politics, and Regulation of Adverse Drug Reactions 5 Regulating Drugs, Regulating Diseases: Consumerism and the US Tolbutamide Controversy
• 6 Thalidomide, Drug Safety Regulation, and the British Pharmaceutical Industry: The Case of Imperial Chemical Industries 7 What's in a Pill? On the Informational Enrichment of Anti-Cancer Drugs
• 8 Treating Health Risks or Putting Healthy Women at Risk: Controversies around Chemoprevention of Breast Cancer 9 AZT and Drug Regulatory Reform in the Late 20th-Century US
• 10 Professional, Industrial, and Juridical Regulation of Drugs: The 1953 Stalinon Case and Pharmaceutical Reform in Postwar France
• This collection takes the perspective that the historiography of science, technology, and medicine needs a broader approach toward regulation. The authors explore the distinct social worlds involved in regulation, the forms of evidence and expertise mobilized, and means of intervention chosen to tame drugs in factories, consulting rooms and courts.
• English